There is a paucity of biomarkers that reliably detect nephrotoxicity. The Predictive Safety Testing Consortium (PSTC) faced several challenges in identifying novel safety biomarkers in the renal setting.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The role of N-methyladenosine modification in acute and chronic kidney diseases
Molecular Medicine Open Access 08 December 2023
-
Nephrotoxicity evaluation and proteomic analysis in kidneys of rats exposed to thioacetamide
Scientific Reports Open Access 27 April 2022
-
Associations of CKD risk factors and longitudinal changes in urine biomarkers of kidney tubules among women living with HIV
BMC Nephrology Open Access 30 August 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout

References
Mehta, R.L. et al. Kidney Int. 66, 1613–1621 (2004).
Blowey, D.L. Adolesc. Med. Clin. 16, 31–43 (2005).
Mutlib, A.E. et al. Toxicol. Appl. Pharmacol. 169, 102–113 (2000).
Perazella, M.A. Clin. J. Am. Soc. Nephrol. 4, 1275–1283 (2009).
Kellum, J.A., Levin, N., Bouman, C. & Lameire, N. Curr. Opin. Crit. Care 8, 509–514 (2002).
Vaidya, V.S. et al. Nat. Biotechnol. 28, 478–485 (2010).
Wingard, J.R. et al. Clin. Infect. Dis. 29, 1402–1407 (1999).
Molitoris, B.A. et al. J. Am. Soc. Nephrol. 18, 1992–1994 (2007).
Chertow, G.M., Burdick, E., Honour, M., Bonventre, J.V. & Bates, D.W. J. Am. Soc. Nephrol. 16, 3365–3370 (2005).
Waikar, S.S. & Bonventre, J.V. J. Am. Soc. Nephrol. 20, 672–679 (2009).
Dieterle, F. et al. Nat. Biotechnol. 28, 455–462 (2010).
Vaidya, V.S., Ferguson, M.A. & Bonventre, J.V. Annu. Rev. Pharmacol. Toxicol. 48, 463–493 (2008).
Ferguson, M.A., Vaidya, V.S. & Bonventre, J.V. Toxicology 245, 182–193 (2008).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
R.S. and F.D. are employees of Novartis and P.F. is an employee of Merck.
Rights and permissions
About this article
Cite this article
Bonventre, J., Vaidya, V., Schmouder, R. et al. Next-generation biomarkers for detecting kidney toxicity. Nat Biotechnol 28, 436–440 (2010). https://doi.org/10.1038/nbt0510-436
Issue date:
DOI: https://doi.org/10.1038/nbt0510-436
This article is cited by
-
Body mass index and implications for pediatric kidney health: a cross-sectional study with urinary biomarkers
Pediatric Nephrology (2024)
-
The role of N-methyladenosine modification in acute and chronic kidney diseases
Molecular Medicine (2023)
-
Drug induced nephrotoxicity- A mechanistic approach
Molecular Biology Reports (2023)
-
Nephrotoxicity evaluation and proteomic analysis in kidneys of rats exposed to thioacetamide
Scientific Reports (2022)
-
Biomimetic models of the glomerulus
Nature Reviews Nephrology (2022)